ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.